Pharmafile Logo
Pharmafocus logo
Advanced Search
161201120435_1_900x600

New molecular-binding technique promises accelerated drug development

December 5, 2016
Research and Development, Sales and Marketing Alzheimer's, Cancer, Indiana University-Purdue University Indianapolis

Researchers at the School of Science at Indiana University-Purdue University Indianapolis (IUPUI) have claimed to have designed a new molecular …

News
novartis_building

Novartis posts 82% remission rate in CAR T paediatric study

December 5, 2016
Research and Development, Sales and Marketing CAR T, CAR-T, Novartis, leukaemia, paediatric

Novartis has released the results of its global, paediatric study of the treatment of leukaemia in children and young adults …

News

Pfizer teams up with IBM Watson Health in immuno-oncology

December 2, 2016
Medical Communications Pfizer, Watson, Watson Health, drug discovery, ibm

Pfizer and IBM Watson Health have announced a joint venture to accelerate research in immuno-oncology. Pfizer will use IBM’s Watson …

News
top_ten_1

Top Ten most popular articles on Pharmafile this week

December 2, 2016
Medical Communications November, news, pharmaceutical, top 10, top ten, top ten stories

This week has been an interesting one for pharmaceutical innovation. A number of stories and studies have arisen about trialling …

News

Looking back at the biggest deal of 2016: Bayer-Monsanto

December 2, 2016
Medical Communications Bayer, acquisition, big deal, monsanto, pharma deal 2016

The industry followed Bayer’s attempts to acquire US agricultural firm Monsanto with fevered anticipation; the takeover eventually closed in September …

News
shutterstock_274590824

J&J hit by $1bn hip implant lawsuit

December 2, 2016
Medical Communications J&J, JJ, lawsuit

Johnson & Johnson have been hit with yet another payout to patients who claim its products caused them harm. First, …

News
astrazeneca_building_white

AstraZeneca seals $1 billion deal with Bicycle Therapeutics

December 2, 2016
Medical Communications, Sales and Marketing AstraZeneca, Bicycle Therapeutics

Bicycle Therapeutics, Cambridge-based British biotech firm, has announced that it has signed a deal that could potentially be worth over …

News
merckincweb1

NICE approves MSD’s Keytruda for new cancer indication

December 1, 2016
Medical Communications, Sales and Marketing MSD, NICE, keytruda

The National Institute of Health and Care Excellence (NICE) has announced its recommendation of MSD’s immunotherapy drug Keytruda (pembrolizumab) for …

News
kitepharma_fullcolor_rgb

Kite Pharma names new senior VP of Supply Chain

December 1, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointment, kite pharma

Santa-Monica-based clinical-stage biopharmaceutical firm Kite Pharma has appointed Dr Jian Irish as senior vice president of Supply Chain, who will …

Appointment
takeda_tokyo_hq

Takeda to build €100 million dengue vaccine manufacturing plant

December 1, 2016
Manufacturing and Production, Medical Communications Takeda, dengue, phase 3

Takeda have announced plans to spend more than €100 million in the construction of a new manufacturing plant in Singen, …

News
eisai_halaven_eribulin_web

Eisai & Clinigen to bring breast cancer drug to South Africa

December 1, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Clinigen, Eisai, South Africa, breast cancer

Eisai and Clinigen have formed a collaboration to deliver the former’s cancer treatment Halaven (eribulin) to women in South Africa …

News
ncri-harpal-hero

Cancer Research UK announces “largest ever” development investment

December 1, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer Research UK

Cancer Research UK (CRUK) is set to inject a total of £226 million into centres across the UK over the …

News
happy_doctor

Illegal psilocybin shows promise in treatment of depression

December 1, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Johns Hopkins, Magic mushrooms, psilocybin

A double-blind study of psilocybin, the hallucinogenic drug chemical found in ‘magic mushrooms’,  has been found to have substantial mental …

News
shutterstock_291014192

NICE recommends GSK’s “first-in-class” asthma drug

November 30, 2016
Sales and Marketing GSK, NICE, Nucala, asthma

NICE has announced its recommendation of GSK’s “first-in-class” biologic Nucala (mepolizumab) as an extra option for the treatment of adults …

News
blood-75302_640

Researchers develop capsule-based haemophilia treatment tech

November 30, 2016
Research and Development University of Texas, haemophilia

Researchers at the University of Texas have developed a new method for treating haemophilia B which utilises a biodegradable oral …

News

Teva to shut down Maltese plant, axe 210 jobs

November 30, 2016
Manufacturing and Production, Research and Development Actavis Generics, Allergan, Malta, Teva

Teva is set to axe 210 jobs and shut down a production plant in Malta in an effort to cut …

News
advanced_manufacturing_building_site_uon

£25m flagship manufacturing & research facility for University of Nottingham

November 30, 2016
Manufacturing and Production, Research and Development University of Nottingham

Earlier this month, the University of Nottingham began work on a ‘pioneering’ Advanced Manufacturing Building. The £25 million, 9,011 square-metre …

News
humira_abbott_

Humira biosimilar proves efficacy in Phase 3 trial

November 30, 2016
Research and Development AbbVie, Amgen, FDA, Humira, M923, Momenta

US-based biotechnology firm Momenta Pharmaceuticals has announced that its biosimilar version of Abbvie’s autoimmune drug Humira (adalimumab) – currently the …

News
shutterstock_204190579

MDMA trials get FDA backing for PTSD treatment

November 30, 2016
Research and Development FDA, MDMA, PTSD

The FDA have given the go-ahead to Phase 3 clinical trials investigating the efficacy of MDMA (Methylenedioxymethamphetamine) for treating post-traumatic …

News
actinium_pharma

Actinium snatches up ex-Novartis clinical manager

November 29, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Actinium, Novartis, appointment

Actinium Pharmaceuticals has appointed Gregory Bergonio to the position of director of Clinical Operations, where he will first guide the …

Appointment
The Gateway to Local Adoption Series

Latest content

Sandoz launches allergy relief nasal spray in Germany and Switzerland

April 9, 2026

Japan approve Daiichi Sankyo’s Enhertu as a second-line treatment for gastric cancer

April 9, 2026

Trelleborg to take part in Medtec Japan 2026

April 8, 2026

Kainova Therapeutics expands phase I/II trial of antibody drug

April 7, 2026

Eisai starts enrolment for phase 2 narcolepsy study evaluating E2086

April 7, 2026